| ACP | Amorphous calcium phosphate |
| BA | Boronopicolinic acid |
| BC | Breast cancer |
| BCSCs | Breast cancer stem cells |
| BRCA | Breast Cancer susceptibility gene |
| CDK | Cyclin-dependent kinase |
| CDSCO | Central Drug Standards Control Organization of India |
| CPT | Camptothecin |
| DAV | Drug Administration of Vietnam |
| DTX | Docetaxel |
| EGCG | Epigallocatechin gallate |
| EGFR | Epidermal growth factor receptor |
| EMA | European Medicines Agency |
| EMT | Epithelial–mesenchymal transition |
| EPR | Enhanced permeability and retention |
| ER | Estrogen receptor |
| FA | Folic acid |
| FDA | Food and Drug Administration |
| GA | Gallic acid |
| GOQD | Graphene oxide quantum dots |
| GSH | Glutathione |
| Gem | Gemcitabine |
| HA | Hyaluronic acid |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hormone receptor |
| HSP 70 | Heat shock protein 70 |
| IFP | Interstitial fluid pressure |
| L-MSNs | Lipid-coated mesoporous silica nanoparticles |
| LCST | Lower critical solution temperature |
| LHRH | Luteinizing hormone-releasing hormone |
| MFDS | Ministry of Food and Drug Safety |
| MIONPs | Magnetic iron oxide nanoparticles |
| MMP-2 | Matrix metallopeptidase 2 |
| MMP-9 | Matrix metallopeptidase 9 |
| MOF | Modified metal–organic framework |
| MSNs | Mesoporous silica nanoparticles |
| NP | Nanoparticle |
| NDDS | Nanoparticle-based delivery systems |
| NIR | Near-infrared |
| NMPA | National Medical Products Administration |
| NRP-1 | Neuropilin-1 |
| PARP | Poly(ADP-ribose) polymerase |
| PCMs | Phase change materials |
| PD-1 | Programmed cell death 1 |
| PD-L1 | Programmed death-ligand 1 |
| PDH | Philippines: Department of Health |
| PDT | Photodynamic therapy |
| PEG | Polyethylene glycol |
| PFP | Perfluoropentane |
| P-gp | P-glycoprotein |
| PL | Piperonamide |
| PLL | PEGylated poly-L-lysine |
| PNIPAM | Poly(N-isopropylacrylamide) |
| PPA | Pyro-de-magnesium chlorophyll-a |
| PPRM | Pyropheophorbide-a (Ppa) micelle |
| PPY | Polypyrrole |
| PR | Progesterone receptor |
| PS | Photosensitizers |
| PTT | Photothermal therapy |
| PTX | Paclitaxel |
| RFMPH | Russian Federation: Ministry of Public Health |
| RGD | Arg-Gly-Asp |
| ROS | Reactive oxygen species |
| SA | Sialic acid |
| SDT | Sonodynamic therapy |
| SELEX | Systematic evolution of ligands by exponential enrichment |
| SLNs | Solid lipid nanoparticles |
| SPIONs | Superparamagnetic iron oxides |
| THZ | Thioridazine |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| TNF | Tumor necrosis factor |
| Tf | Transferrin |
| Trop-2 | Trophoblast cell-surface antigen 2 |
| VEGF | Vascular endothelial growth factor |
| ZIF-8 | Zeolitic imidazolate framework-8 |
| shRNA | small hairpin RNA |